Titanium Zirconium (TiZr) Mini Implants

NCT ID: NCT03837158

Last Updated: 2024-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2033-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

H0: "Within the first year post-placement, four interforaminally placed, immediately loaded 2.4 mm narrow-diameter one-piece TiZr implants with miniaturized stud-type attachments show improved patient-reported outcome measures (PROMS) compared to two interforaminally placed, early loaded, TiZr two-piece implants with stud-type attachments to retain a mandibular overdenture."The specific aim is to compare both treatment alternatives to evaluate which one may be recommended for elderly edentulous patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Implants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control-group

Two Tissue Level TiZr Sand blasted long grit acid-etched (SLA) implants placed in positions 33 and 43 (diameter 3.3mm, length ≥10mm), early loading

Group Type EXPERIMENTAL

early loading

Intervention Type PROCEDURE

two TiZr implants on SLA surface

Experimental-group

Four narrow-diameter implants (NDI) TiZr SLA implants in positions 34, 32, 42, and 44 (diameter 2.4mm, length ≥10mm), immediate loading

Group Type EXPERIMENTAL

immediate loading

Intervention Type PROCEDURE

four TiZr implants on SLA surface

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

early loading

two TiZr implants on SLA surface

Intervention Type PROCEDURE

immediate loading

four TiZr implants on SLA surface

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At patient level:

* Written informed consent
* Age ≥ 18 years
* Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year
* Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment
* At site level:

* Healed edentulous mandible (minimum 8 weeks since last extraction)
* Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants
* Opposing dentition: complete denture on a edentulous maxilla
* Physical status (PS) 1 and 2 (American Society of Anesthesiologists)

Exclusion Criteria

* At patient level

* Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol
* Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates
* Pregnancy or lactation
* Heavy smoking habit with \> 20 cig/d
* Severe bruxism or clenching habits, present oro-facial pain
* At site level:

* Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Bern

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beat Wallkamm, Dr

Role: PRINCIPAL_INVESTIGATOR

Private Practice

Martin Schimmel, Prof

Role: STUDY_DIRECTOR

University of Bern

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Private Practice Dr. B. Wallkamm

Langenthal, Canton of Bern, Switzerland

Site Status

University of Bern

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mini 1286_2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RCT Comparing KS Versus TS for Ovedenture
NCT06276712 NOT_YET_RECRUITING NA